SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid discussions around the release of Epstein files and their potential implications for Trump. The stock's performance and the company's financials are being scrutinized, with some traders pointing to insider selling and questioning the company's long-term viability. Community sentiment appears divided, with strong opinions both for and against the stock.

Cycurion, Inc. engages in custom solutions to organizations for information technology and cybersecurity needs. The company was founded on February 14, 2025 and is headquartered in McLean, VA.

Cycurion Inc.

CYCU is trending due to news of a recent contract win and regaining NASDAQ compliance, sparking community interest. Discussions revolve around the potential for a short squeeze, given the stock's low float and cybersecurity market exposure. Some traders are eyeing a run to higher price levels, while others caution about potential volatility and dilution.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending due to a White House memo alleging the company provides technology supporting Chinese military operations targeting the US, sparking community debate about potential delisting and national security concerns. Some investors view the news as FUD or market manipulation, while others express patriotism and call for divestment. The community is also discussing the timing of the news in relation to Alibaba's recent Qwen chat app release and upcoming earnings.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital ($APLD) is trending as investors debate its future amid infrastructure buildout and AI sector volatility. The community is focused on the company's newest campus, Polaris Forge 2, and its potential for powering large-scale AI deployments. Concerns remain about high debt and dilution risk in the sector, contributing to market-wide selling.

Cidara Therapeutics, Inc. engages in developing targeted immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. Its platform, Cloudbreak, enables development of novel drug-Fc conjugates (DFCs) that inhibit specific disease targets while simultaneously engaging the immune system. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Cidara Therapeutics Inc

Cidara Therapeutics is trending as investors discuss its potential acquisition following strong performance data and a recent FDA Breakthrough Therapy designation for its flu treatment candidate, CD388. Community members are speculating on potential bidding wars and the impact of this development on the broader biotech sector, especially regarding flu treatment visibility. Bullish sentiment is high, with some anticipating significant long-term growth and re-evaluation of the company's value.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as the community debates whether the recent market dip was a bear trap, with many pointing to a strong recovery and potential for new all-time highs. Traders are actively discussing the impact of institutional buying, options flow, and upcoming earnings reports, particularly $NVDA, on the index's direction. Some are wary of overbought conditions and potential for a pullback, while others remain bullish, anticipating further gains into year-end.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros is trending as the community discusses the potential for FDA approval of Narsoplimab by late December, alongside the Novo Nordisk deal. Community members are speculating on the likelihood of approval and potential buyout offers following a competitor's acquisition news. The stock's price movement and trading volume are also being closely watched for signals.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as traders assess market direction heading into the weekend, with community members debating whether recent price action signals a bull trap or a genuine recovery. Discussions also revolve around potential volatility catalysts, including upcoming economic data and geopolitical tensions, as well as the influence of large institutional players.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending as investors assess the impact of a recent analyst downgrade ahead of upcoming earnings. The community is debating the company's valuation, buyback potential, and competitive pressures, especially concerning investments in new business ventures. Some traders express frustration with the stock's performance relative to its peers and the broader market, while others remain optimistic about its long-term prospects.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending due to the FDA's decision to add a black box warning to Elevidys and limit its use to ambulatory DMD patients, which sparked mixed reactions. While the stock initially rose on investor relief that the drug wasn't pulled entirely, the community is now debating the impact of excluding non-ambulatory patients and awaiting potential analyst upgrades. Discussions also include speculation about a possible buyout, given BlackRock's increased stake in the company.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why ARCA Biopharma Shares Are Trading Higher Today

ARCA Biopharma shares are trading higher by 8.1% Monday morning. The company announced a special dividend of $1.59 per share.
read more...

SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate ABIO, MODN, DPSI, AIRC

SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate ABIO, MODN, DPSI, AIRC SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate ABIO, MODN, DPSI, AIRC PR Newswire NEW YORK, June 5...

Shareholder Alert: Ademi LLP investigates Disclosure Issues involving ARCA biopharma, Inc.'s Transaction with Oruka

Shareholder Alert: Ademi LLP investigates Disclosure Issues involving ARCA biopharma, Inc.'s Transaction with Oruka Shareholder Alert: Ademi LLP investigates Disclosure Issues involving ARCA...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, HIBB, ABIO, HMNF

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, HIBB, ABIO, HMNF SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, HIBB, ABIO, HMNF PR Newswire NEW YORK, May 23, 2024 NEW...

Kuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law Firm

Kuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law Firm Kuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law Firm PR Newswire NEW YORK, May 22, 2024 NEW YORK...

ARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of ARCA biopharma, Inc. (the Company) (NasdaqCM...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO PR Newswire NEW YORK, April 10, 2024 NEW...

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA...

ARCA biopharma (NASDAQ:ABIO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of ARCA biopharma (NASDAQ:ABIO - Free Report) in a research note released on Thursday. The firm issued a sell rating on the biopharmaceutical company's stock...

ARCA biopharma (NASDAQ:ABIO) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of ARCA biopharma (NASDAQ:ABIO - Get Free Report) in a note issued to investors on Thursday. The firm set a "sell" rating on the...

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

ARCA biopharma Inc

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$27.26
Prev Close	$26.38
Open	$26.58
Dividend Yield	0.00%
50-Day Moving Average	$22.39
Beta	0.91
Avg. Volume	439,856.04
PE Ratio	-10.91

52-Week High	$29.98
52-Week Low	$5.49
Market Capitalization	$1.28B
EPS (Annual)	-$4.99
Price to Book	2.64
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ABIO
ARCA biopharma Inc

Feed

News

Sentiment

Fundamentals

Info

Latest ABIO News

ABIOARCA biopharma Inc